World's Best Scientists 2026 revealed!
Award Badge
Immunology
Norway
2026

D-Index & Metrics

Immunology

D-Index
98
Citations
45651
World Ranking
778
National Ranking
5

Medicine

D-Index
99
Citations
46055
World Ranking
8466
National Ranking
33

Terje Espevik publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Terje Espevik sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 341 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Terje Espevik D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Terje Espevik sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Norway Leader Award
  • 2025 - Research.com Immunology in Norway Leader Award
  • 2022 - Research.com Immunology in Norway Leader Award
  • Member of the Norwegian Academy of Science and Letters Biochemistry, Biophysics, and Molecular Biology
  • Member of the Norwegian Academy of Science and Letters Biochemistry, Biophysics, and Molecular Biology
  • Member of the Norwegian Academy of Science and Letters Biochemistry, Biophysics, and Molecular Biology
  • Member of the Norwegian Academy of Science and Letters Biochemistry, Biophysics, and Molecular Biology

Overview

Terje Espevik is affiliated with the Norwegian University of Science and Technology in Norway. Their research activity focuses on immunology, molecular biology, and medicine, with substantial contributions across the fields of Biochemistry, Genetics, and Molecular Biology.

Espevik's main research areas cover topics such as inflammasomes and immune disorders, the complement system in diseases, immune response and inflammation, interferon and immune responses, atherosclerosis and cardiovascular diseases, NF-κB signaling pathways, and immune cell function and interaction.

Frequent publication venues for Espevik include:

  • The Journal of Immunology (6 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (5 publications)
  • Frontiers in Immunology (2 publications)
  • Immunobiology (2 publications)
  • Science Immunology (1 publication)

Some of the recent papers authored or co-authored by Espevik are:

  • "Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation" (2021) published in Science Immunology
  • "Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis" (2020) published in EBioMedicine
  • "Multi-OMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells" (2022) published in iScience
  • "TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram-positive bacteria" (2020) published in Journal of Leukocyte Biology
  • "Caspase-8 inhibition improves the outcome of bacterial infections in mice by promoting neutrophil activation" (2023) published in Cell Reports Medicine

Espevik frequently collaborates with other researchers, including Liv Ryan, Tom Eirik Mollnes, Maria Yurchenko, Astrid Skjesol, and Nathalie Niyonzima, with whom Espevik has co-authored multiple publications.

Espevik is a member of the Norwegian Academy of Science and Letters in the section of Biochemistry, Biophysics, and Molecular Biology.

Best Publications

  • NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

    Peter Duewell;Hajime Kono;Katey J. Rayner;Katey J. Rayner;Cherilyn M. Sirois

  • TLR9 signals after translocating from the ER to CpG DNA in the lysosome

    Eicke Latz;Annett Schoenemeyer;Alberto Visintin;Katherine A. Fitzgerald

  • A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

    Terje Espevik;Jon Nissen-Meyer

  • The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

    A Waage;P Brandtzaeg;A Halstensen;P Kierulf

  • Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

    A. Waage;A. Halstensen;T. Espevik

  • TOLL-LIKE RECEPTOR 2 FUNCTIONS AS A PATTERN RECOGNITION RECEPTOR FOR DIVERSE BACTERIAL PRODUCTS

    Egil Lien;Egil Lien;Timothy J. Sellati;Atsutoshi Yoshimura;Trude H. Flo

  • The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF

    Kai-Uwe Belge;Farshid Dayyani;Alexia Horelt;Maciej Siedlar

  • Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming

    Anette Christ;Anette Christ;Patrick Günther;Mario A.R. Lauterbach;Peter Duewell

  • Soluble CD14 participates in the response of cells to lipopolysaccharide.

    E A Frey;D S Miller;T G Jahr;A Sundan

  • The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation

    Bernardo S Franklin;Lukas Bossaller;Dominic De Nardo;Jacqueline M Ratter

  • A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization.

    Desiree van der Kleij;Desiree van der Kleij;Eicke Latz;Jos F.H.M. Brouwers;Yvonne C.M. Kruize

  • Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

    Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen

  • Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

    Eicke Latz;Alberto Visintin;Egil Lien;Egil Lien;Katherine A. Fitzgerald

  • Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

    G E Ranges;I S Figari;T Espevik;M A Palladino

  • Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

    A Waage;A Halstensen;R Shalaby;P Brandtzaeg

  • Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity

    Harald Husebye;Øyvind Halaas;Harald Stenmark;Harald Stenmark;Gro Tunheim

  • Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.

    T Espevik;I S Figari;M R Shalaby;G A Lackides

  • Ligand-induced conformational changes allosterically activate Toll-like receptor 9

    Eicke Latz;Anjali Verma;Alberto Visintin;Mei Gong

  • The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

    Øystein Sandanger;Trine Ranheim;Leif Erik Vinge;Leif Erik Vinge;Marte Bliksøen

  • Inflammatory Response After Open Heart Surgery: Release of Heat-Shock Protein 70 and Signaling Through Toll-Like Receptor-4

    Brit Dybdahl;Alexander Wahba;Egil Lien;Trude H. Flo

  • Erratum: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals (Nature (2010) 464 (1357-1361))

    Peter Duewell;Hajime Kono;Katey J. Rayner;Cherilyn M. Sirois

Frequent Co-Authors

Tom Eirik Mollnes
Tom Eirik Mollnes Oslo University Hospital
Gudmund Skjåk-Bræk
Gudmund Skjåk-Bræk Norwegian University of Science and Technology
Egil Lien
Egil Lien University of Massachusetts Chan Medical School
Anders Sundan
Anders Sundan Norwegian University of Science and Technology
Eicke Latz
Eicke Latz German Rheumatism Research Centre
Pål Aukrust
Pål Aukrust Oslo University Hospital
Stig S. Frøland
Stig S. Frøland University of Oslo
Douglas T. Golenbock
Douglas T. Golenbock University of Massachusetts Chan Medical School
Olav Smidsrød
Olav Smidsrød Norwegian University of Science and Technology
Anders Waage
Anders Waage Norwegian University of Science and Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into healthcare roles such as nursing can offer rewarding career paths. Exploring the cheapest psychiatric nurse practitioner programs is a smart choice for students looking to minimize education costs while gaining specialized skills in mental health.

Advancing to a Doctorate in Nursing Practice (DNP) can significantly impact your earning potential. Understanding doctorate in nursing salary trends across states helps in making informed decisions about where to study and work post-graduation.

For nurse practitioners, pursuing an acute care certification for fnp offers a clear pathway to expand clinical expertise in critical care settings, enhancing career flexibility and scope of practice.

Many students benefit from enrolling in accelerated np programs, which expedite the journey to becoming a nurse practitioner through intensive, flexible online coursework.

Combining foundational Immunology knowledge with these nursing pathways can open doors to specialized roles in healthcare, research, or policy, making your education both versatile and impactful.

Best Scientists Citing Terje Espevik

Trending Scientists

Recently Published Articles